Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks

被引:217
作者
Knutson, Sarah K. [1 ]
Chyla, Brenda J. [1 ]
Amann, Joseph M. [1 ,2 ]
Bhaskara, Srividya [1 ]
Huppert, Stacey S. [3 ]
Hiebert, Scott W. [1 ,4 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
chromatin; Hdac3; histone acetylation; metabolism;
D O I
10.1038/emboj.2008.51
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone deacetylase 3 (Hdac3) is an enzymatic component of transcriptional repression complexes recruited by the nuclear hormone receptors. Inactivation of Hdac3 in cancer cell lines triggered apoptosis, and removal of Hdac3 in the germ line of mice caused embryonic lethality. Therefore, we deleted Hdac3 in the postnatal mouse liver. These mice developed hepatomegaly, which was the result of hepatocyte hypertrophy, and these morphological changes coincided with significant imbalances between carbohydrate and lipid metabolism. Loss of Hdac3 triggered changes in gene expression consistent with inactivation of repression mediated by nuclear hormone receptors. Loss of Hdac3 also increased the levels of Ppar gamma 2, and treatment of these mice with a Ppar gamma antagonist partially reversed the lipid accumulation in the liver. In addition, gene expression analysis identified mammalian target of rapamycin signalling as being activated after deletion of Hdac3, and inhibition by rapamycin affected the accumulation of neutral lipids in Hdac3-null livers. Thus, Hdac3 regulates metabolism through multiple signalling pathways in the liver, and deletion of Hdac3 disrupts normal metabolic homeostasis.
引用
收藏
页码:1017 / 1028
页数:12
相关论文
共 68 条
[1]   TRANSLOCATION BREAKPOINT OF ACUTE PROMYELOCYTIC LEUKEMIA LIES WITHIN THE RETINOIC ACID RECEPTOR-ALPHA LOCUS [J].
ALCALAY, M ;
ZANGRILLI, D ;
PANDOLFI, PP ;
LONGO, L ;
MENCARELLI, A ;
GIACOMUCCI, A ;
ROCCHI, M ;
BIONDI, A ;
RAMBALDI, A ;
LOCOCO, F ;
DIVERIO, D ;
DONTI, E ;
GRIGNANI, F ;
PELICCI, PG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1977-1981
[2]   ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain [J].
Amann, JM ;
Nip, J ;
Strom, DK ;
Lutterbach, B ;
Harada, H ;
Lenny, N ;
Downing, JR ;
Meyers, S ;
Hiebert, SW .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) :6470-6483
[3]   The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression [J].
Ashburner, BP ;
Westerheide, SD ;
Baldwin, AS .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) :7065-7077
[4]  
BHASKARA S, 2008, IN PRESS MOL CELL
[5]   The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes [J].
Brown, Nicholas F. ;
Stefanovic-Racic, Maja ;
Sipula, Ian J. ;
Perdomo, German .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (11) :1500-1507
[6]   The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A [J].
Chakrabarti, SR ;
Nucifora, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (03) :871-877
[7]   Thermogenic and metabolic antiobesity drugs: rationale and opportunities [J].
Clapham, J. C. ;
Arch, J. R. S. .
DIABETES OBESITY & METABOLISM, 2007, 9 (03) :259-275
[8]   Histone deacetylases (HDACs): characterization of the classical HDAC family [J].
De Ruijter, AJM ;
Van Gennip, AH ;
Caron, HN ;
Kemp, S ;
Van Kuilenburg, ABP .
BIOCHEMICAL JOURNAL, 2003, 370 :737-749
[9]   Many facets of mammalian lanosterol 14α-demethylase from the evolutionarily conserved cytochrome P450 family CYP51 [J].
Debeljak, N ;
Fink, M ;
Rozman, D .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 409 (01) :159-171
[10]   The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation [J].
Fajas, L ;
Egler, V ;
Reiter, R ;
Hansen, J ;
Kristiansen, K ;
Debril, MB ;
Miard, S ;
Auwerx, J .
DEVELOPMENTAL CELL, 2002, 3 (06) :903-910